This decision analysis is based on:
1- Comparative Effectiveness Research, Indirect and Mixed Treatment Comparisons (MTC, NMA) : Positioning your innovative technology in the studied therapeutic area;
2- Interactive Health Economics Modeling: Assessing the cost-effectiveness, the cost-utility or the cost-benefit of your innovative health product or technology;
3- Interactive Budget Impact Analysis (IBIA) : Assessing the affordability of your innovative product;
4- Medico-economic real life studies.